Related by context. All words. (Click for frequent words.) 79 baseline CD4 76 median CD4 72 absolute lymphocyte 72 CD4 + cell 68 baseline CD4 + 67 neutrophil count 66 cells μL 65 CD4 cell 65 CD4 + 64 lymphocyte count 64 leukocytosis 64 leukocyte count 62 mm ³ 62 HbA 1c levels 61 CD4 lymphocytes 61 neutrophil counts 61 lymphocytosis 61 eosinophil count 60 cubic milliliter 60 HOMA IR 60 serum urate levels 60 mIU ml 60 antibody titer 60 HBeAg seroconversion 60 troponin T 60 HBV DNA levels 60 cells/mm3 60 plasma leptin 60 seropositivity 60 μmol L 59 pCR 59 microliter 59 normalize platelet 59 microlitre 59 undetectable viral 59 PSA nadir 59 cells uL 59 erythrocyte sedimentation rate 59 Viral load 59 severe neutropenia 59 granulocyte 59 plasma folate 59 serum urate 59 serum HBV DNA 59 HbA1C levels 59 undetectable viral loads 58 mcL 58 ± SEM 58 posttransplant 58 serum homocysteine 58 serum creatinine levels 58 HER2 expression 58 HIV RNA 58 anagrelide 58 albumin excretion 58 baseline LDH 58 RBC folate 58 recurrent VTE 58 concentration Cmax 58 anti HBs 58 hours postdose 58 pmol L 58 mmHg diastolic 58 serum phosphate levels 58 median survivals 58 complete cytogenetic response 58 Hb A1C 58 haematological toxicity 58 SUVmax 58 virologic failure 58 intramuscular dose 58 serum testosterone 57 serum LDL cholesterol 57 homocysteine concentrations 57 lymphocyte counts 57 % CI #.#-#.# [008] 57 cubic millimeter 57 MMSE scores 57 endometrial thickness 57 hemoglobin Hb 57 thyrotropin levels 57 sUA levels 57 CHD mortality 57 serum concentrations 57 log# copies mL 57 % CI #.#-#.# [003] 57 definite stent thrombosis 57 CD# upregulation 57 pT3 57 leukocyte counts 57 glycosylated hemoglobin HbA1c 57 tertile 57 #.#ng/ml 57 -#.# log# copies mL 57 #OHD 57 octreotide LAR 57 hemoglobin A1c levels 57 urine albumin 57 urate lowering therapy 57 specific antigen PSA 57 glycated hemoglobin levels 57 mL/min/#.# m 2 57 IU ml 57 cells mcL 57 posttreatment 57 folate concentrations 57 elevated LDH 57 serum IgE 56 A1c levels 56 postoperative mortality 56 serum PSA 56 mmHg systolic 56 -#.# log# 56 CD4 T 56 cytopenias 56 blood glucose concentrations 56 recurrent venous thromboembolism 56 serum prostate 56 fructosamine 56 lactate dehydrogenase 56 aminotransferase 56 biochemical relapse 56 nonpregnant women 56 albumin excretion rate 56 experienced virologic failure 56 telomere lengths 56 QTcF 56 attain statistical significance 56 transaminase levels 56 advanced neoplasia 56 virological suppression 56 baseline HbA1c 56 seroconverted 56 elevated bilirubin 56 serum albumin 56 histologic subtype 56 serum cortisol 56 hemoglobin concentration 56 alanine aminotransferase ALT 56 CD4 + cells 56 confidence intervals CIs 56 nanograms milliliter 56 remission CR 56 Pred Forte 56 Kaplan Meier 56 undetectable viral load 56 highest tertile 56 Triglyceride levels 56 serum calcium levels 56 viral titers 55 peripheral neuropathy disabling 55 lactate dehydrogenase LDH 55 pg ml 55 log# reduction 55 intracranial hemorrhage ICH 55 inflammatory biomarkers 55 CD3 + 55 triglyceride concentrations 55 symptomatic intracranial hemorrhage 55 sUA 55 nanomolar 55 Kaplan Meier estimate 55 serum estradiol 55 hydroxyvitamin D levels 55 evaluable subjects 55 RBC transfusions 55 PSADT 55 seroprotection 55 mm3 55 baseline neutrophil counts 55 KRAS mutations 55 virologic suppression 55 PASI scores 55 platelet reactivity 55 serum HCV RNA 55 mean ± SEM 55 serum aminotransferase levels 55 CD4s 55 MMSE score 55 p = #.# [003] 55 Serum creatinine 55 hemoglobin A1c HbA1c 55 aspartate aminotransferase 55 paraprotein 55 glomerular filtration 55 dose cohort 55 serum lipid levels 55 aspartate aminotransferase AST 55 interquartile range 55 undetectable HBV DNA 55 serum phosphate 55 ng dL 55 seroconversion 55 CR nPR 55 hemoglobin concentrations 55 alanine aminotransferase 55 umbilical artery 55 8 OHdG 55 CIN3 55 serum magnesium 55 systolic blood pressures 55 HbA1C 55 resected pancreatic cancer 55 serum sodium levels 55 μg d 55 serum potassium levels 55 absolute neutrophil count 55 bioavailable testosterone 55 ASCUS 55 Hgb 55 CCyR 55 achieved sustained virological 55 fosamprenavir 55 CD4 counts 54 μg ml 54 DAS# CRP 54 μg L 54 corticosterone levels 54 nmol liter 54 faecal egg 54 CVD mortality 54 leukopenia 54 CD4 + T 54 ALT elevation 54 detectable HCV RNA 54 preoperative PSA 54 fetal malformations 54 umol L 54 multivariable analysis 54 serum PTH 54 serum antibody 54 urinary cadmium 54 colorectal adenoma 54 HBsAg 54 protein excretion 54 micromoles 54 serum CRP 54 Insulin sensitivity 54 sustained virological response 54 salivary flow 54 parasitaemia 54 β blockers 54 TPV r 54 % Confidence Interval 54 antigen PSA levels 54 triacylglycerol concentrations 54 β blocker 54 poor metabolizers 54 serum potassium 54 Kaplan Meier analysis 54 NHANES III 54 clodronate 54 plasma HCV RNA 54 #OHD levels 54 virologic response 54 univariate analysis 54 Inhibin B 54 tryptase 54 nondiabetic patients 54 anemia hemoglobin 54 systolic dysfunction 54 thyroglobulin 54 HBeAg 54 achieved ACR# 54 Hb A1c 54 HbA 1c 54 nmol L. 54 mmol l 54 milliliters mL 54 NIH CPSI 54 plasma cortisol 54 creatinine ratio 54 mEq L 54 serum uric acid 54 parous women 54 rebleeding 54 LV dysfunction 54 serum vitamin D 54 EDSS score 54 viral titer 54 Kaplan Meier method 54 REYATAZ r arm 54 progression TTP 54 lowest tertile 54 mg/m2 dose 54 nonvertebral fracture 54 intima media thickness 54 statistical significance p 53 hepatitis C genotype 53 Homocysteine levels 53 creatinine levels 53 prospectively defined 53 perioperative mortality 53 femoral neck BMD 53 invasive ductal 53 HIV HCV coinfected 53 dysglycemia 53 serum calcium 53 ejection fractions 53 #mmHg [001] 53 CD4 lymphocyte count 53 neurologic complications 53 doxorubicin docetaxel 53 μg liter 53 operable breast cancer 53 relapsed MM 53 HbA1c levels 53 serum folate 53 diastolic pressures 53 elevated triglyceride levels 53 odds ratios ORs 53 lymphopenia 53 chlamydial infection 53 urinary iodine 53 regression coefficient 53 adenoma recurrence 53 splenectomized patients 53 EDSS scores 53 serum ferritin 53 BCG vaccinated 53 mmol liter 53 bFGF 53 thrombocytopenic 53 antibody titers 53 plasma renin activity 53 extracapsular extension 53 virological response 53 EpCAM expression 53 shorter telomere length 53 advanced adenoma 53 lobular cancer 53 tipranavir r 53 antiretroviral naïve 53 K ras mutations 53 polyp recurrence 53 autoantibody levels 53 serum ALT 53 thyroid stimulating hormone 53 elevated ALT 53 serum clusterin levels 53 prolactin levels 53 #.#mmol L [002] 53 nondiabetics 53 thyrotropin 53 NNRTI resistance 53 HBeAg negative patients 53 dalteparin 53 ischemic lesions 53 symptomatic intracerebral hemorrhage 53 BLLs 53 timepoints 53 lumbar spine BMD 53 chronic HBV 53 serum IGF 53 Breslow thickness 53 DAS# [002] 53 HCV genotype 53 fasting triglycerides 53 adiponectin concentrations 53 HBV infections 53 #mmHg [002] 53 elevated creatinine 53 IgG antibody 53 ductal cancer 53 gastric carcinoma 53 leucopenia 53 steroid dexamethasone 53 ug mL 53 corticosteroid dose 53 Plasma concentrations 53 gastric adenocarcinoma 53 colorectal neoplasia 53 nonnucleoside reverse transcriptase inhibitors 53 candidemia 53 μg dl 53 foveal thickness 53 SHBG levels 53 coinfection 53 Fasting plasma glucose 53 hsCRP levels 53 mutated K ras 53 rFSH 53 liver histology 53 Replikin Count 53 antiretroviral naive 53 mcg dose 52 plasma homocysteine 52 serum IgG 52 receiving ISENTRESS 52 hematologic toxicity 52 serum BDNF 52 NIHSS score 52 morphometric vertebral fractures 52 IU mL 52 glomerular filtration rate 52 retransplantation 52 plasma triglycerides 52 annualized relapse 52 receiving APTIVUS r 52 CMV disease 52 rimonabant #mg 52 fasting glucose levels 52 Ishak fibrosis score 52 elevated transaminases 52 atorvastatin #mg 52 binary restenosis 52 SCIg 52 gout flares 52 mL/min/#.# m2 52 daily subcutaneous injections 52 colorectal adenomas 52 prolonged QT interval 52 genotypic resistance 52 ertapenem 52 CMV infection 52 μg mL 52 p = .# [002] 52 #.#mmol l [002] 52 perimenopausal women 52 argatroban 52 hemoglobin A1C 52 NPH insulin 52 antiandrogen 52 Postoperatively 52 #mg dose [002] 52 biochemical recurrence 52 HBV DNA 52 nonvertebral fractures 52 SGOT 52 latent celiac disease 52 endometrial hyperplasia 52 mm Hg systolic 52 virologic responses 52 platelet counts 52 methylmalonic acid 52 CRp 52 Febrile neutropenia 52 dehydroepiandrosterone sulfate 52 plasma homocysteine levels 52 onset diabetes mellitus 52 antiangiogenic therapy 52 baseline A1C 52 cotrimoxazole 52 Forcible rape 52 thiazides 52 serum retinol 52 SGPT 52 atazanavir ritonavir 52 alteplase 52 normal ULN 52 atypical ductal hyperplasia 52 paricalcitol 52 del 5q myelodysplastic syndromes 52 HAART initiation 52 urate levels 52 salivary cortisol 52 oral FTY# 52 hematologic abnormalities 52 IDDM 52 depressive symptomatology 52 serum folate concentrations 52 generalized edema 52 iPTH 52 Univariate analysis 52 MAGE A3 ASCI 52 dosing cohort 52 ovarian carcinoma 52 magnesium intake 52 ALT flares 52 microg 52 sitosterol 52 CI #.#-#.# [001] 52 aged ≥ 52 follicle stimulating hormone FSH 52 timepoint 52 serum testosterone levels 52 drank pomegranate juice 52 tumor histology 52 nonmelanoma skin cancers 52 CC genotype 52 serum bicarbonate 52 response CCyR 52 Fasting glucose 52 copies ml 51 clinico pathological 51 fluvastatin 51 Median PFS 51 SLNB 51 euthyroid 51 atherosclerotic progression 51 Kaplan Meier survival 51 multivariable adjusted 51 MCyR 51 neutropaenia 51 fasting triglyceride levels 51 ADCS ADL 51 spontaneous preterm birth 51 serum glucose 51 ug ml 51 ribavirin therapy 51 postoperative delirium 51 serum sodium 51 adiponectin levels 51 recurrent UTI 51 IFN α 51 antidiabetic medication 51 ApoE4 carriers 51 CD4 cells 51 receiving antiretroviral therapy 51 hemodialysis patients 51 baseline Hb 51 hemagglutination inhibition 51 milligrams deciliter 51 arterial thickening 51 KRAS mutations occur 51 mIU L 51 triglyceride concentration 51 glycosylated hemoglobin levels 51 pmol liter 51 abacavir lamivudine 51 severe hypoglycemic episodes 51 aminotransferase ALT 51 acromegalic patients 51 MS relapses 51 T1DM 51 transferrin saturation 51 elevated fasting glucose 51 HGPIN 51 underwent surgical resection 51 intraocular pressure IOP 51 corrected QT interval 51 glycated hemoglobin HbA1c 51 cTnT 51 estimated glomerular filtration 51 microbiologically evaluable 51 FOLFIRI alone 51 chlamydial 51 eculizumab therapy 51 carotid plaque 51 indinavir 51 external genital lesions 51 p = NS 51 cTnT levels 51 clinically meaningful improvement 51 tHcy 51 mg ustekinumab 51 IGFBP 51 fasting insulin 51 hepatitis B immunoglobulin 51 postintervention 51 tertiles 51 Cmax 51 Calcium intake 51 nonobese 51 mRS 51 elevated hsCRP 51 CD4 51 #ng/ml 51 underwent resection 51 flutamide 51 ibandronate 51 prostate cancer CaP 51 nonexposed 51 LDL cholesterol concentrations 51 atherogenic dyslipidemia 51 glulisine 51 Crohn Disease Activity 51 myocardial infarctions MIs 51 low dose Iluvien 51 parasitemia 51 Skin sterol 51 prior chemotherapy regimens 51 nocturnal hypoglycaemia 51 viremia 51 APTIVUS r 51 colorectal carcinoma 51 cEVR 51 autoantibody positive 51 undetectable HCV RNA 51 ventricular enlargement 51 hepatocellular carcinomas 51 UGT#A# * 51 neutropenic 51 TT genotype 51 Exploranium GR #G 51 dose Iluvien 51 virological failure 51 plasma viremia 51 BARACLUDE ® 51 Telintra 51 neurologic progression 51 aminotransferase levels 51 adult chronic ITP 51 nonfasting triglyceride levels 51 comparator arm 51 intravascular hemolysis 51 rFVIIa 51 deep venous thromboses 51 undetectable hepatitis C 51 transgene expression 51 asymptomatic carotid stenosis 51 IV bisphosphonates 51 g dl 51 HIV uninfected 51 cranial irradiation 51 viral loads 51 sustained virologic response 51 serum phosphorus levels 51 % CI #.#-#.# [007] 51 recurrent genital herpes 51 tipranavir ritonavir 51 Operative mortality 50 advanced adenomas 50 insulin detemir 50 BRCA mutation carriers 50 URTI 50 metastatic GIST 50 hepatorenal syndrome 50 rectal gonorrhea 50 nmol l 50 heterozygotes 50 antibody titres 50 aminotransferases 50 Lupuzor ™ 50 postoperative complication 50 diastolic BP 50 hip BMD 50 Retreatment 50 NAbs 50 bacteriuria 50 Folfox 50 hepatic enzymes 50 postprocedure 50 neurologic outcomes 50 Rectal cancer 50 PASI score 50 prospectively stratified 50 selenium supplementation 50 thyroid hormone levels 50 VELCADE melphalan 50 conditional logistic regression 50 postprandial glycemia 50 seronegative 50 locoregional recurrence 50 triiodothyronine 50 plasma pharmacokinetics 50 EGFR TKI 50 seroprotective 50 urinary cortisol 50 MELD scores 50 nonmetastatic 50 IUGR 50 precancerous cervical 50 HSCT 50 lipid elevations 50 gm dl 50 hematopoietic cancers 50 Index CDAI 50 seropositive patients 50 LDL HDL 50 endometrial carcinoma 50 P = .# 50 viral load 50 subclinical cardiovascular disease 50 nephrotoxicity 50 MetS 50 brachial artery flow 50 EGFR mutation positive 50 diastolic blood pressures 50 perioperative morbidity 50 rizatriptan 50 symptomatic intracranial 50 ABC/3TC 50 Durezol 50 virologic breakthrough 50 atrophic gastritis 50 elevated troponin 50 CHADS2 50 macroalbuminuria 50 QALE 50 APOE e4 50 viraemia 50 Kaplan Meier estimates 50 gastric cardia 50 carotid IMT 50 estrogen progestin therapy 50 malignant neoplasm 50 hypogonadal men 50 Legg Calvé Perthes disease 50 hypophosphatemia 50 HIV seroconversion 50 Neutrophil 50 LEXIVA r 50 maximal doses 50 epithelial ovarian cancer 50 NRTI resistance 50 BRCA2 mutation carriers 50 Multicenter AIDS 50 iNO 50 nucleotide analog 50 #Gy 50 certolizumab 50 myeloperoxidase 50 coinfected 50 spontaneous preterm delivery 50 atheroma volume 50 VTEs 50 highest quintile 50 virus HBV 50 CDI recurrence 50 mCRPC 50 microscopic hematuria 50 testicular tumors 50 virologic 50 rhGH 50 initiating antiretroviral therapy 50 adjunctive placebo 50 ug dose 50 treatment naive genotype 50 TDF FTC 50 #mg BID [001] 50 ELBW infants 50 pulmonary dysfunction 50 univariate analyzes 50 #.#mmHg 50 #.#/#.# mmHg [001] 50 blood Phe 50 nonpregnant 50 NT proBNP concentrations 50 titers 50 PAOD 50 Fasting blood glucose 50 adjuvant cisplatin 50 fractional anisotropy 50 #.#/#.# mm Hg [003] 50 peak plasma concentrations 50 endothelial activation 50 SVR# 50 genital herpes infections 50 cortisol concentrations 50 PBMCs 50 low dose cytarabine 50 arterial oxygen saturation 50 anovulatory infertility 50 genotype 1b 50 transaminase elevations 50 virologic response EVR 50 intermittent dosing 50 confidence interval #.#-#.# 50 del 5q MDS 50 peak VO2 50 anemia neutropenia 50 ipsilateral stroke 50 X ULN 50 vincristine doxorubicin 50 hypoglycaemic episodes 50 Visual acuity 50 mCi m 2 50 serum parathyroid hormone 50 nadolol 50 K#N 50 postoperative morbidity 50 Fasting glucose levels 50 tamoxifen Nolvadex ® 50 mg kg dose 50 isolated systolic hypertension 50 seminoma 50 mammographic density 50 multivariate Cox 50 A1C levels 50 comparator PI r 50 HAQ DI 50 ELISPOT 50 Baseline characteristics 50 mcg BID 50 HBeAg negative 50 arterial thromboembolic events 50 HCV replicon 50 CLA supplementation 50 creatinine clearance 50 PHPT 50 blood Phe levels 50 non squamous NSCLC 50 IRLS score 50 pulmonary capillary wedge 50 naïve HCV 50 suboptimal adherence 50 serum cholesterol 50 mucosal healing 50 HBeAg positive 50 ductal breast cancer 50 biopsy Gleason 50 clinically evaluable patients 50 underwent liver transplantation 49 HI titers 49 fibrosis progression 49 hepatocellular carcinoma liver 49 lupus anticoagulant 49 cytogenetic responses 49 hepatic insulin sensitivity 49 haematologic 49 dapagliflozin plus 49 3mg/kg 49 Postoperative complications 49 genital secretions 49 BPH Symptom Score 49 CK MB 49 elevated CRP 49 mycophenolate 49 incidence ≥ 49 urinary excretion 49 metabolic parameters 49 RBP4 levels 49 piperacillin tazobactam 49 μg kg 49 complete cytogenetic 49 GBA mutations 49 glycaemia 49 thiazide diuretics 49 #mg/day [001] 49 KRAS mutant tumors 49 grade astrocytomas 49 C. difficile colitis 49 DAS# remission 49 platelet count 49 pg mL 49 distant metastasis 49 inhospital 49 lopinavir r arm 49 palivizumab 49 ApoB 49 apolipoprotein B 49 multivariate adjustment 49 heavily pretreated 49 plasma uric acid 49 mcg doses 49 vasogenic edema 49 hypogonadal 49 FeNO 49 nonmelanoma skin cancer 49 lowering blood glucose 49 Infusion Reactions Severe 49 SCr 49 Natalizumab 49 μg doses 49 systolic pressure 49 benign noncancerous 49 systemic toxicity 49 postvaccination 49 mg simvastatin 49 mcg albinterferon alfa 2b 49 felony misbranding 49 bivariate analyzes 49 oligohydramnios 49 serum triglycerides 49 prevalent vertebral fracture 49 multiple logistic regression 49 nephrotoxic drugs 49 endophthalmitis 49 mRCC 49 virologic failures 49 acarbose 49 heFH 49 Hemoglobin A1c 49 severe rotavirus gastroenteritis 49 abdominal adiposity 49 nitrotyrosine 49 OGTT 49 osteosarcomas 49 blood phenylalanine Phe 49 concomitant antibiotics 49 peripheral blood mononuclear 49 polytherapy 49 achieved CCyR 49 Hb levels 49 glycosylated hemoglobin 49 ROC curves 49 Arch Intern Med 49 prolactin elevation 49 recurrent myocardial infarction 49 achieved statistical significance 49 Tysabri infusions 49 nondepressed 49 neurodevelopmental outcome 49 D dimer 49 cisplatin chemotherapy 49 aromatase inhibitor therapy 49 neurodevelopmental outcomes 49 MRSA bloodstream infection 49 Secondary efficacy endpoints 49 mean baseline A1C 49 NNT = 49 logistic regression models 49 log# IU mL 49 Prostate Specific Antigen PSA 49 symptomatic VTE 49 divalproex sodium 49 Myocardial infarction 49 abnormal lipid 49 IELT 49 triacylglycerol 49 preeclamptic 49 noncancer 49 hepatic enzyme 49 hormone receptor negative 49 Virologic 49 oxygen desaturation 49 baseline serum creatinine 49 CDAI score 49 cerebral oxygenation 49 cardiovascular hospitalizations 49 postoperative infection 49 imipenem 49 AST ALT 49 IPAH 49 bolus dose 49 low expressors 49 HAART regimen 49 liver transplant recipients 49 adefovir treated 49 RSV hospitalizations 49 ASD prevalence 49 mercury concentrations 49 ng dl 49 cGy 49 PSQI 49 hypoglycemic events 49 PRADAXA #mg 49 NYHA functional class 49 chronic HCV genotype 49 mediated immunity 49 plasma glucose 49 reactogenicity 49 squamous cell lung cancer 49 lopinavir ritonavir Kaletra 49 intravaginal ejaculatory latency 49 oncologic outcomes 49 chronic hepatitis cirrhosis 49 CD4 count 49 ml kg 49 cART 49 CANCIDAS 49 nondiabetic 49 intraoperative complications 49 interferon ribavirin 49 gonococcal infection 49 IFN alfa 49 placebo dexamethasone 49 morphological abnormalities 49 postop 49 retrospective cohort 49 systolic BP 49 GnRH agonist 49 CD8 T cell 49 clinically insignificant 49 CPAP adherence 49 oxycodone CR 49 intravenous diuretics 49 dosing frequency 49 waist circumference measurements 49 plasma urate 49 elevated LDL cholesterol 49 #-# mg dL 49 mg m² 49 chlorambucil 49 prostate specific 49 serum leptin 49 trastuzumab Herceptin ® 49 invasive aspergillosis 49 Free Survival PFS 49 NovoLog ® Mix 49 plasma glucose levels 49 gm dL 49 CIMZIA TM certolizumab pegol 49 impaired glucose metabolism 49 preterm newborns 49 pegylated interferon alfa 49 de ath 49 incontinence episodes 49 â ‰ ¥ 49 osteopenic 49 dietary folate 49 nmol L 49 moderately emetogenic 49 microvascular complications 48 amoxicillin clavulanate 48 upper gastrointestinal bleeding 48 elevated IOP 48 preterm neonates 48 Charlson comorbidity index 48 kg m² 48 logistic regression analyzes 48 carotid plaques 48 basal cell nevus syndrome 48 dexamethasone Decadron 48 μg dose 48 TEAEs 48 multivariate regression analysis 48 CYP#D# genotype